News

An Insightful Look Into Progressive Corp's Recent Results

An Insightful Look Into Progressive Corp's Recent Results

September Results Overview

Progressive Corporation (NYSE: PGR) has released a comprehensive report detailing its results for September and the quarter ending on September 30. Highlighting notable financial performances, the company has reported substantial gains in net premiums written and earned, along with insights into their net income.

Net Premiums Written

In the latest reporting period, the company achieved impressive growth in net premiums written, totaling $7,128 million for September 2025, compared to $6,570 million in September 2024. This represents an increase of 8%. Furthermore, for the quarterly total, Progressive reported net premiums written reaching $21,384 million, showcasing a solid increase of 10% compared to the previous year.

Net Premiums Earned Performance

When examining net premiums earned, Progressive recorded $6,827 million in September 2025, which is a significant rise from $6,263 million reported in the same period last year, marking a 9% year-over-year growth. For the quarter, net premiums earned touched $20,849 million up from $18,297 million, a remarkable 14% increase, indicating robust business momentum.

Net Income Insights

Turning to net income, Progressive reported $305 million for September 2025, representing a notable decrease of 48% from the previous year's $585 million. Although this decline may raise questions, the quarterly figure of $2,615 million up from $2,334 million in the same quarter of the previous year, reflects a growth of 12% and indicates strong business operations despite the month’s setback.

Per Share Earnings

With respect to per share earnings available to common shareholders, the company posted $0.52 for September, down 48% from $0.99 a year ago, while for the quarter, earnings were noted at $4.45, reflecting a 12% growth from the previous $3.97 per share.

Combined Ratio and Realized Gains

Progressive's combined ratio also reflects a significant increase, reported at 100.4 for the quarter, compared to 93.4 from the previous year, indicating that while costs are increasing, the company is still managing to grow its business and maintain profitability. The total pretax net realized gains from securities were $138 million for September, highlighting the company's adept handling of investments.

Policies in Force Update

In terms of policies in force, Progressive continues to expand its presence with a total of 38,078 policies in force as of September 30, 2025, up by 12% from 33,869 policies the previous year. This robust growth in policies signifies the trust and confidence consumers have in Progressive's offerings.

Personal and Commercial Lines

Looking into specifics, the total personal lines policies were at 36,880 in September, which is a considerable jump from 32,738 in 2024, showcasing a 13% uplift. Meanwhile, commercial lines saw a modest rise, indicating stable growth in that segment as well.

About Progressive Corporation

Established in 1937, Progressive has been at the forefront of providing accessible and understandable insurance solutions. Known as the second largest personal auto insurer in the U.S., it also offers policies for boats, motorcycles, and homes. Progressive prides itself on customer-centric tools that help streamline the insurance buying process, ensuring consumers get the best value for their needs.

The Common Shares of The Progressive Corporation, based in Mayfield Village, Ohio, are publicly traded under the ticker NYSE: PGR.

Company Contact:
Douglas S. Constantine
(440) 395-3707
investor_relations@progressive.com

The Progressive Corporation
300 North Commons Blvd.
Mayfield Village, Ohio 44143
http://www.progressive.com

Frequently Asked Questions

1. What were Progressive's net premiums written for September 2025?

Progressive reported net premiums written of $7,128 million for September 2025.

2. How did the net income for September 2025 compare to the previous year?

In September 2025, net income was $305 million, which is a 48% decrease from the previous year's $585 million.

3. What is the number of policies in force for Progressive as of September 30, 2025?

The number of policies in force was 38,078, displaying a 12% increase compared to the previous year.

4. How has Progressive's combined ratio changed over the year?

The combined ratio was reported at 100.4 for the recent quarter, compared to 93.4 last year, indicating an increase in costs.

5. What is Progressive Corporation known for?

Progressive is the second largest personal auto insurer in the U.S. and provides insurance for various vehicles and homes, emphasizing customer-friendly services.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lassa's Wintus 3: Boosting Winter Tyre Game for 2026

Updated Category News Views 2

Rolling Through Winter: Lassa's Next Step Ever felt like you were skating on thin ice with your vehicle in winter? That's why Lassa has cranked out the Wintus 3—a tyre making waves in the chilly game. Now, we're not talking about your run-of-the-mill rubber. This is a strategic play by a Turkish powerhouse, Brisa, aimed squarely at those who rely on light commercial...

Continue Reading
Dimora Medical Boosts Advanced Wound Care at HS Conference

Updated Category News Views 44

Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...

Continue Reading
Solenis Appoints Brendy Lange to Lead Americas Growth

Updated Category News Views 6

New Leadership at Solenis Change is brewing at Solenis, and it's set to ripple across the water treatment industry like a stone in a pond. Brendy Lange's appointment as Chief Business Officer, Americas, promises to shake things up in a firm as committed to innovation as Solenis. This seasoned executive, scooped from the ranks of Dow Chemical, steps in with a mandate to...

Continue Reading
Ractigen's LiCO™ Platform Hits Extrahepatic Milestones

Updated Category News Views 6

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

Continue Reading
Galien Recognizes Kerry for Transformative Global Health Work

Updated Category News Views 10

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Continue Reading
Cboe Clear's US Move: A New Chapter with SEC Nod

Updated Category News Views 4

Clearing the Path for New Beginnings The ink's barely dry on Cboe Clear U.S.'s recent SEC registration, and it's already setting tongues wagging among market old-timers. This move to clear binary securities options alongside futures isn't just a step up; it's a signal flare for ambitious innovation. The Nuts and Bolts: SEC Registration So, what's the big to-do? Cboe Clear...

Continue Reading
Rakuten Medical's Long-Term Data Shows Promise

Updated Category News Views 5

This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...

Continue Reading
SAFE Structure Designs Backs Prosthetic Nonprofit 50 Legs

Updated Category News Views 3

A Partnership Rooted in Service and Faith Let's face it, support from major companies for nonprofits isn't exactly commonplace. But every so often, you run into a partnership that catches your eye, and this one's got a little extra heart. SAFE Structure Designs, known for its defense engineering prowess in Las Vegas, is throwing its weight behind Clearwater's 50 Legs....

Continue Reading
S&P Global's New Dashboard: Unpacking Data Insights

Updated Category News Views 3

An Interactive Take on Digital Infrastructure The geniuses over at S&P Global Ratings have just unleashed a shiny new tool for number crunchers and market hawks who can't get enough data center action—an interactive dashboard. Maybe not everyone’s cup of tea, but hey, in the dog-eat-dog world of digital infrastructure, any edge counts. What's in the Data Center Soup?...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 5

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading

Top 5 Most Recently Viewed Articles

MediaAlpha Set for Q3 2024 Financial Results Presentation

Updated Category News Views 78

MediaAlpha's Upcoming Financial Report Announcement MediaAlpha, Inc. (NYSE: MAX), based in Los Angeles, has exciting news for its investors and stakeholders. The company is gearing up to announce its financial results for the third quarter of 2024 on an upcoming Wednesday. This announcement will take place after the market closes, providing important insights into the...

Continue Reading
Understanding Recent Trends in Canadian Stocks and Markets

Updated Category News Views 329

Canadian Stock Market Overview Recently, the Canadian stock market experienced a decline, reflecting a challenging trading environment. The decline was multifaceted, with notable tumbles in sectors such as the Consumer Staples, REITs, and Healthcare, which significantly influenced overall market performance. Investors and analysts are keenly observing these fluctuations,...

Continue Reading
Discover Key Trends in Network Observability for IT Success

Updated Category News Views 137

Emerging Trends in Network Observability Join experts as they discuss how IT leaders can adapt observability tools to meet modern network challenges. Enterprise Management Associates (EMA) is hosting an insightful webinar titled "Your NetOps Tools Are Aging Faster Than Your Network: 5 Emerging Trends That Are Reshaping Network Observability." Shamus McGillicuddy, Vice...

Continue Reading
Realbotix Secures Payment in Genesis Restructuring Efforts

Updated Category News Views 74

Realbotix Achieves Major Financial Recovery Realbotix Corp. (TSX-V: XBOT | Frankfurt Stock Exchange: 76M0.F | OTC: XBOTF) is making waves in the news by recently securing a significant cash payment of US$743,500 as part of its ongoing restructuring efforts with Genesis Global Capital. This milestone is a positive step for the Company as it works through the challenges of...

Continue Reading
Immedica Pharma's Loargys: Pioneering Hope in Rare Disease

Updated Category News Views 210

Game-Changing Approval or Just Another Hype Train? Time for a gut check: Immedica Pharma just made waves with its Loargys® (pegzilarginase-nbln), snagging accelerated FDA approval for treating hyperargininemia tied to Arginase 1 Deficiency (ARG1-D). So what's the big deal? Well, basically, we're talking about a breakthrough here—it's the first therapy proven to lower...

Continue Reading